REVB: Revelation Biosciences O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Revelation Biosciences (REVB) uchun PEG koeffitsiyenti bozor kutganlarini aks ettiradi, bunda joriy parametr 0.00 ga tengdir. Ushbu tendentsiya buyrak fibroziga qarshi kurashishga qaratilgan Gemini mahsulotlar liniyasining kengayishi bilan bog'liq. Rahbariyat hamkorlarni jalb qilish uchun tug'ma immunitetni faollashtirishga e'tibor qaratmoqda, biznesni rivojlantirish esa makrotsikldan mustaqil qolgan holda, faqat operatsiyadan keyingi yallig'lanishning oldini olish bo'yicha test natijalariga tayanmoqda.
Revelation Biosciences (REVB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi revbiosciences.com|REVB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Revelation Bio|REVB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Revelation Biosciences|Shoshilinch likvidlik revbiosciences.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
REVB - Sof daromad|Kutilayotgan foyda Revelation Biosciences|REVB - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Revelation Biosciences Corp|REVB - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Revelation Bio|REVB - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Revelation Biosciences|REVB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati revbiosciences.com|REVB - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Revelation Biosciences
Kompaniyaning umumiy tahlili:REVB - Revelation Biosciences Inc
Yagona immun nomzodini ishlab chiqishga e'tibor qaratgan Revelation Biosciences (REVB) uchun PEG koeffitsiyenti bozor qiymati va foyda o'sish sur'ati o'rtasidagi muvozanatni aks ettiradi. Ushbu koeffitsient P/E koeffitsiyentini EPS o'sish sur'atiga bo'ladi: birdan past qiymat aktivning fundamental dinamikasiga nisbatan past baholanganligini anglatadi, bu esa biotexnologiya startaplarini baholash uchun juda muhimdir.
Revelation Biosciences raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PHVS (Pharvaris Pharma)|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda tourmalinebio.com (TRML)|Narx-foyda va o‘sish multiplikatori PGEN|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|PEG multiplikatori NKTR|UPB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|KALV - PEG multiplikatori|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|PVLA: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|RAPT: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|JBIO: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|TLSA (Tiziana Life Sciences Ltd.) - Narxning foydaga va o‘sish sur’atiga nisbati|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|AVTX - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|Climb Bio, Inc. - PEG multiplikatori|zurabio.com (ZURA) - Narx-foyda va o‘sish multiplikatori|ATYR: PEG multiplikatori|ADAG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|IMA (ImageneBio) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Shattuck Therapeutics STTK|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|connectbiopharm.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori IMUX (Immunic)|ATRA - Narx-foyda va o‘sish multiplikatori|InflaRx GmbH - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda X4 Pharmaceuticals Inc.|adicetbio.com (ACET) - Narxning foydaga va o‘sish sur’atiga nisbati|CELU - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|BRNS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori KZR|SABS - O‘sish sur’atiga tuzatilgan narx-foyda|Akari Therapeutics plc - Narx-foyda va o‘sish multiplikatori|Enlivex Therapeutics Ltd - Narxning foydaga va o‘sish sur’atiga nisbati|Q32 Bio Corp - PEG multiplikatori|GOVX: Narxning foydaga va o‘sish sur’atiga nisbati|Edesa Biotech (EDSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IBIO (iBio Inc)|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|XTLB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BOLT|PEG multiplikatori hcwbiologics.com (HCWB)|Narxning foydaga va o‘sish sur’atiga nisbati Aptevo Therapeutics Inc. APVO|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AIM|ADTX - Narxning foydaga va o‘sish sur’atiga nisbati|GRI Bio Corporation (GRI) - Narx-foyda va o‘sish multiplikatori|XRTX: PEG multiplikatori|reshapelifesciences.com (HIND) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori INDP|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|iTeos Therapeutics Inc (ITOS) - Narx-foyda va o‘sish multiplikatori|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
